{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T16:34:55Z","timestamp":1686242095879},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pnpbp.2006.04.023","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T14:50:55Z","timestamp":1150210255000},"page":"1291-1298","source":"Crossref","is-referenced-by-count":8,"title":["Effects of olanzapine on aggressiveness in heroin dependent patients"],"prefix":"10.1016","volume":"30","author":[{"given":"G.","family":"Gerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Petta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"D'Amore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Iannotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bardicchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Falorni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Coacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Strepparola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Campione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vedda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Serio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Manzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Antonioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bertacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Moi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zaimovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.04.023_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0376-8716(97)00061-6","article-title":"Subjects with a history of drug dependence are more aggressive than subjects with no drug use history","volume":"46","author":"Allen","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.04.023_bib2","first-page":"CD003729","article-title":"Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses","author":"Belgamwar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004850-199905030-00005","article-title":"A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial","volume":"14","author":"Berk","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0306-4603(93)90028-8","article-title":"Morphine and human aggression","volume":"18","author":"Berman","year":"1993","journal-title":"Addict Behav"},{"issue":"5\u20136","key":"10.1016\/j.pnpbp.2006.04.023_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eurpsy.2005.01.009","article-title":"Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)","volume":"20","author":"Bitter","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib6","first-page":"237","article-title":"Multidisciplinary examinations of the \u201ccauses\u201d of crime: the case of the link between alcohol and violence","volume":"21","author":"Brain","year":"1986","journal-title":"Alcohol Alcism"},{"issue":"Suppl 10","key":"10.1016\/j.pnpbp.2006.04.023_bib7","first-page":"52","article-title":"The role of typical and atypical anti-psychotic medications in the management of agitation and aggression","volume":"60","author":"Buckley","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/h0046900","article-title":"An inventory for assessing different kinds of hostility","volume":"21","author":"Buss","year":"1957","journal-title":"J Consult Psychol"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-9964(98)00146-7","article-title":"Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro","volume":"37","author":"Bymaster","year":"1999","journal-title":"Schizophr Res"},{"issue":"5582","key":"10.1016\/j.pnpbp.2006.04.023_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1072290","article-title":"Role of genotype in the cycle of violence in maltreated children","volume":"297","author":"Caspi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib11","series-title":"Recurrent mood disorders","first-page":"51","article-title":"Aggressive behaviour and hostility in depression: clinical aspects","author":"Castrogiovanni","year":"1993"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00131746-200105000-00002","article-title":"Olanzapine use in subjects with pervasive developmental disorder displaying aggression and\/or self-mutilation","volume":"7","author":"Chengappa","year":"2001","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.04.023_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00435849","article-title":"Effects of smoking different doses of nicotine on human aggressive behavior","volume":"75","author":"Cherek","year":"1981","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.pnpbp.2006.04.023_bib14","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1176\/appi.ps.52.11.1510","article-title":"Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility in patients with schizophrenia and schizoaffective disorder","volume":"52","author":"Citrome","year":"2001","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib15","series-title":"SCL-90-R: Administration, scoring and procedure manual-II","author":"Derogatis","year":"1992"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401230209147450","article-title":"The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists","volume":"14","author":"Dording","year":"2002","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/cap.1998.8.73","article-title":"Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive\u2013compulsive disorder","volume":"8","author":"Go","year":"1998","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib19","series-title":"Intervista Clinica Strutturata per il DSM-III-R","author":"Fava","year":"1993"},{"issue":"12","key":"10.1016\/j.pnpbp.2006.04.023_bib18","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1176\/ajp.154.12.1760","article-title":"Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine","volume":"154","author":"Fava","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.pnpbp.2006.04.023_bib21","first-page":"39","article-title":"New anti-psychotics: the present status","volume":"10","author":"Gerlach","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000119129","article-title":"Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder\/hyperactivity and conduct disorder","volume":"30","author":"Gerra","year":"1994","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/1355621031000069846","article-title":"Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects","volume":"8","author":"Gerra","year":"2003","journal-title":"Addict Biol"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.04.023_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004850-200309000-00002","article-title":"Neuroendocrine and behavioural responses to opioid receptor\u2013antagonist durino heroin detoxification: relationship with personality traits","volume":"18","author":"Gerra","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.04.023_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00702-004-0129-8","article-title":"Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates","volume":"111","author":"Gerra","year":"2004","journal-title":"J Neural Transm"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.04.023_bib27","first-page":"351","article-title":"Acting out and psychoactive substances: alcohol, drugs, illicit substances","volume":"27","author":"Gillet","year":"2001","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3956(01)00020-6","article-title":"Treatment with atypical anti-psychotics: new indications and new populations","volume":"35","author":"Glick","year":"2001","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0376-8716(00)00109-5","article-title":"Patterns of improvement after methadone treatment: 1\u00a0year follow-up results from the National Treatment Outcome Research Study (NTORS)","volume":"60","author":"Gossop","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.pnpbp.2006.04.023_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10673229909017206","article-title":"Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?","volume":"6","author":"Green","year":"1999","journal-title":"Harv Rev Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.04.023_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.ALC.0000125352.06688.F7","article-title":"A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder","volume":"28","author":"Guardia","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(98)00048-1","article-title":"Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts","volume":"80","author":"Handelsman","year":"1998","journal-title":"Psychiatry Res"},{"issue":"10","key":"10.1016\/j.pnpbp.2006.04.023_bib33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4088\/JCP.v64n1018","article-title":"Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial","volume":"64","author":"Janowsky","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2006.04.023_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01308-6","article-title":"alpha2C-Adrenoceptor blockade by clozapine and other anti-psychotic drugs","volume":"462","author":"Kalkman","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0404.1996.tb00380.x","article-title":"Treatment of non-cognitive symptoms in dementia. Irritability and aggressiveness respond to the treatment with SSRI drugs","volume":"168","author":"Karlsson","year":"1996","journal-title":"Acta Neurol Scand Suppl"},{"issue":"12","key":"10.1016\/j.pnpbp.2006.04.023_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4088\/JCP.v59n1206","article-title":"Divalproex sodium for impulsive aggressive behavior in patients with personality disorder","volume":"59","author":"Kavoussi","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 3","key":"10.1016\/j.pnpbp.2006.04.023_bib38","first-page":"4","article-title":"The efficacy of atypical anti-psychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia","volume":"61","author":"Keck","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.pnpbp.2006.04.023_bib39","first-page":"17","article-title":"Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia","volume":"62","author":"Kinon","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.04.023_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/cap.1998.8.107","article-title":"Open-label olanzapine treatment in five preadolescent children","volume":"8","author":"Krishnamoorthy","year":"1998","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004714-199706000-00012","article-title":"Selective serotonin reuptake inhibitor-induced serotonin syndrome: review","volume":"17","author":"Lane","year":"1997","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.pnpbp.2006.04.023_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1592\/phco.24.13.1177.38089","article-title":"Paradoxical reactions to benzodiazepines: literature review and treatment options","volume":"24","author":"Mancuso","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib43","first-page":"89","article-title":"Increased aggressive, violent, and impulsive behaviour in patients during chronic-prolonged benzodiazepine use","volume":"45","author":"Mathew","year":"2000","journal-title":"Can J Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2006.04.023_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-1913-8","article-title":"Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression","volume":"176","author":"New","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.04.023_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/cap.2005.15.270","article-title":"Unanswered questions regarding atypical anti-psychotic use in aggressive children and adolescents","volume":"15","author":"Patel","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib46","series-title":"Structured interview for personality disorders, revised version","author":"Pfohl","year":"1989"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib47","first-page":"121","article-title":"Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses","volume":"18","author":"Potvin","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2006.04.023_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-1781(99)00020-7","article-title":"Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism","volume":"86","author":"Samochowiec","year":"1999","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.pnpbp.2006.04.023_bib50","first-page":"452","article-title":"Potential benefits of quetiapine in the treatment of substance dependence disorders","volume":"29","author":"Sattar","year":"2004","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.04.023_bib51","first-page":"278","article-title":"Violent paradoxal reactions secondary to the use of benzodiazepines","volume":"153","author":"Senninger","year":"1995","journal-title":"Ann Med Psychol (Paris)"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.04.023_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00787-002-0265-3","article-title":"A clinical case series of six extremely aggressive youths treated with olanzapine","volume":"11","author":"Soderstrom","year":"2002","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004850-199007000-00005","article-title":"The effects of codeine on human aggressive responding","volume":"5","author":"Spiga","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib54","series-title":"Structured clinical interview according to DSM-III-R","author":"Spitzer","year":"1990"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.04.023_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-200015010-00003","article-title":"Effective open-label treatment of Tourette's disorder with olanzapine","volume":"15","author":"Stamenkovic","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.04.023_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/1044546041648959","article-title":"Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome \u2014 a pilot study","volume":"14","author":"Stephens","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"10.1016\/j.pnpbp.2006.04.023_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4088\/JCP.v59n1202","article-title":"Use of atypical neuroleptics in child and adolescent psychiatry","volume":"59","author":"Toren","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2006.04.023_bib58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/ajp.156.7.1119a","article-title":"Clozapine for substance-abusing schizophrenic patients","volume":"156","author":"Tsuang","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The Overt Aggression Scale for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.04.023_bib59","first-page":"22","article-title":"Pharmacologic management of aggression in the elderly","volume":"51","author":"Yudofsky","year":"1990","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2006.04.023_bib61","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4088\/JCP.v65n0704","article-title":"A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine\u2013fluoxetine combination in women with borderline personality disorder","volume":"65","author":"Zanarini","year":"2004","journal-title":"J Clin Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:25:22Z","timestamp":1683483922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0278584606001850"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.04.023","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}